|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
144,920,000 |
Market
Cap: |
31.60(B) |
Last
Volume: |
4,330,403 |
Avg
Vol: |
713,315 |
52
Week Range: |
$134.65 - $240.96 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 516 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co. operates in two segments: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
11,216 |
19,919 |
91,669 |
273,878 |
Total Sell Value |
$2,046,664 |
$3,371,391 |
$18,560,004 |
$58,777,802 |
Total People Sold |
2 |
4 |
7 |
10 |
Total Sell Transactions |
3 |
6 |
27 |
72 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ghoshal Kaushik |
President, SaaS Business |
|
2021-11-16 |
4 |
A |
$254.81 |
$2,334,569 |
D/D |
9,162 |
15,586 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2021-11-16 |
4 |
A |
$254.81 |
$18,158,270 |
D/D |
71,262 |
487,220 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2021-11-16 |
4 |
A |
$254.81 |
$11,673,101 |
D/D |
45,811 |
67,077 |
|
- |
|
Burt Carol |
Director |
|
2021-11-15 |
4 |
S |
$270.80 |
$321,440 |
D/D |
(1,187) |
0 |
|
6% |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2021-11-15 |
4 |
AS |
$271.75 |
$2,174,000 |
D/D |
(8,000) |
21,266 |
|
-6% |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2021-11-15 |
4 |
OE |
$58.24 |
$465,920 |
D/D |
8,000 |
29,266 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2021-11-11 |
4 |
D |
$259.47 |
$1,063,827 |
D/D |
(4,100) |
69,112 |
|
- |
|
Ghoshal Kaushik |
President, SaaS Business |
|
2021-11-11 |
4 |
D |
$259.47 |
$253,243 |
D/D |
(976) |
6,424 |
|
- |
|
Farrell Peter C |
Director |
|
2021-11-11 |
4 |
D |
$259.47 |
$88,739 |
D/D |
(342) |
191,624 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2021-11-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
110,485 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2021-11-11 |
4 |
OE |
$101.64 |
$99,912 |
D/D |
983 |
120,485 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2021-11-11 |
4 |
D |
$259.47 |
$401,919 |
D/D |
(1,549) |
119,502 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2021-11-11 |
4 |
D |
$259.47 |
$245,199 |
D/D |
(945) |
21,266 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2021-11-11 |
4 |
D |
$259.47 |
$2,269,844 |
D/D |
(8,748) |
415,958 |
|
- |
|
De Witte Jan |
Director |
|
2021-11-11 |
4 |
D |
$259.47 |
$26,985 |
D/D |
(104) |
4,033 |
|
- |
|
Sandercock Brett |
Chief Financial Officer |
|
2021-11-10 |
4 |
AS |
$260.58 |
$651,450 |
D/D |
(2,500) |
84,833 |
|
-7% |
|
Sandercock Brett |
Chief Financial Officer |
|
2021-11-10 |
4 |
OE |
$57.76 |
$144,400 |
D/D |
2,500 |
87,333 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2021-11-03 |
4 |
AS |
$264.29 |
$392,471 |
D/D |
(1,485) |
120,987 |
|
-3% |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2021-10-15 |
4 |
AS |
$255.77 |
$2,046,160 |
D/D |
(8,000) |
22,149 |
|
-3% |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2021-10-15 |
4 |
OE |
$58.24 |
$465,920 |
D/D |
8,000 |
30,149 |
|
- |
|
Sandercock Brett |
Chief Financial Officer |
|
2021-10-11 |
4 |
AS |
$253.37 |
$1,266,850 |
D/D |
(5,000) |
84,786 |
|
-7% |
|
Sandercock Brett |
Chief Financial Officer |
|
2021-10-11 |
4 |
OE |
$57.76 |
$144,400 |
D/D |
2,500 |
89,786 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2021-10-08 |
4 |
D |
$246.52 |
$57,686 |
D/D |
(234) |
75,577 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2021-10-04 |
4 |
AS |
$260.79 |
$387,795 |
D/D |
(1,487) |
122,472 |
|
-8% |
|
Hollingshead James |
President, Sleep Business |
|
2021-10-01 |
4 |
AS |
$261.33 |
$627,183 |
D/D |
(2,400) |
74,479 |
|
-7% |
|
1262 Records found
|
|
Page 10 of 51 |
|
|